Epsilon M&A Deal Report - Laboratoire Tradiphar
Transaction Multiples for the Valuation of Private Companies
Cooper Consumer Health / Laboratoire Tradiphar
No EMAT :
113842
Announced Date :
10/11/2020
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Cooper Consumer Health
Target :
Laboratoire Tradiphar
Country :
Nord
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Founded in 1989, Laboratoire Tradiphar is a pharmaceutical company that manufactures, promotes and distributes a wide range of OTC products in France and abroad . > The portfolio of marketed brands...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
|
|
| Current |
|
|
|
|
|
|
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
| Date | Acquirer | Target | Country | Multiples | See details |
| 29/03/2018 | Cerba Healthcare International | Histalim | Hérault | ** | 113797 |
| 18/06/2022 | Private Group led by Ardian | Groupe Simago | Paris | * | 113760 |
Source: Epsilon Research / EMAT
